Multiple myeloma is rare, but is one of the most common tumors of bone and bone marrow. Annually, there are about six to eight new cases per 100,000 inhabitants. Almost all patients develop from an asymptomatic premalignant stage. Treatment is divided into initial therapy of asymptomatic or symptomatic myeloma and treatment of relapsed disease.